AZN.L

AstraZeneca PLC LSE · AZN.L

$12,702.00 +210.00 (+1.68%)

Pullback · -0.60σ

+ Compare Open in Sniper

Valuation

Market cap $197.0B

P/E (ttm) 25.7

Forward P/E 14.8

Beta (5y) 0.23

Shares out 1,550.9M

Div yield 1.89%

Profitability & returns

ROE 23.5%

Net margin 17.2%

FCF margin 10.8%

Debt / equity 0.72

Trading information

Last price $12702.00

Day range $12504.00 – $12778.00

52-wk range $9892.00 – $15732.00

Avg volume 2.3M

RSI (2) 80.4

Trend zone Pullback

52-week range · today's price

$9892.00$15732.00

Company

Sector Healthcare

Industry Drug Manufacturers - General

Exchange LSE

Next earnings 2026-07-27

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company offers Imjudo, Datroway, Iressa, Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Crestor, Andexxa, Onglyza, Symlin, XIGDUO XR, Atacand, Atacand HCT, Atacand Plus, Farxiga/Forxiga, Plendil, Modip, Splendil, Munobal, Flodil, …